tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Memphasys Shares Halted Pending Key Regulatory Milestone Announcement

Story Highlights
  • Memphasys has secured a trading halt on its ASX-listed shares from 24 December 2025.
  • The halt precedes an announcement on a key regulatory milestone, hinting at a material development.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Memphasys Shares Halted Pending Key Regulatory Milestone Announcement

Claim 70% Off TipRanks This Holiday Season

Memphasys Ltd ( (AU:MEM) ) just unveiled an update.

Memphasys Limited has requested and been granted a trading halt on its shares on the Australian Securities Exchange from the open of trading on 24 December 2025, with the halt to remain in place until either the release of a pending market announcement or the commencement of normal trading on 30 December 2025. The company says the halt is needed to manage its continuous disclosure obligations while it prepares an announcement regarding a key regulatory milestone, signalling that a potentially material regulatory development is imminent for the business and its shareholders.

The most recent analyst rating on (AU:MEM) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Memphasys Ltd stock, see the AU:MEM Stock Forecast page.

More about Memphasys Ltd

Memphasys Limited (ASX: MEM) is an Australian-listed company whose shares trade on the Australian Securities Exchange. The company operates from Homebush West, New South Wales, and is subject to ASX Listing Rules and continuous disclosure obligations as a public issuer of ordinary shares.

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$13.07M

For a thorough assessment of MEM stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1